Evidence map›Paper›PMID 34382595›Full record

ReviewZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2021

Lung adenocarcinoma misdiagnosed as IgG4-related lung disease: A case report and literature review.

Yingjiao Long, Xiaopeng Liu, Yuqi Zhao, Jie Qing, Ke Zhang, Hong Peng

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yingjiao LongDepartment of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha 410011.
Xiaopeng LiuDepartment of Critical Care Medicine, Hunan Want Want Hospital, Changsha 410016.
Yuqi ZhaoDepartment of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha 410011.
Jie QingDepartment of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha 410011.
Ke ZhangDepartment of Pathology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Hong PengDepartment of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha 410011.
Second Xiangya Hospital of Central South University · CN

Funding

the National Key Clinical Specialty Construction Project 2012-650the National Natural Science Foundation 81800043the Natural Science Foundation of Hunan 2020JJ5818
6 · The paper itself

Abstract

IgG4-related disease (IgG4-RD) is a recently recognized disorder characterized by elevated serum IgG4 levels and infiltration of IgG4 positive blood cells in the affected organs. However, other conditions like malignancy as well as connective tissue diseases, may show similar findings. A 56-year-old male patient visited Second Xiangya Hospital, Central South University for recurrent fever and chest pain for more than 1 month. Preliminary tests diagnosed as IgG4-related lung disease (IgG4-RLD). However, the improvement of symptoms was absent after the treatment with methylprednisolone. The patient underwent the second biopsy and the result eventually demonstrated lung adenocarcinoma. The role of IgG4 in the pathogenesis or prognosis for lung adenocarcinoma remains unclear. Therefore, a thorough evaluation of symptoms, test of specific serum markers and eventually pathological confirmation are required to avoid misdiagnosis.

Indexed as

Adenocarcinoma of LungImmunoglobulin G4-Related DiseaseLung DiseasesLung NeoplasmsDiagnostic ErrorsHumansImmunoglobulin GMaleMiddle AgedImmunoglobulin GIgG4-positive plasma cellIgG4-related diseaseIgG4-related lung diseaselung adenocarcinoma

Identifiers

PMID34382595
PMCPMC10930119
OpenAlexW3191727824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.